المؤلفون: van Hazel, G.A., Heinemann, V., Sharma, N.K., Findlay, M.P.N., Ricke, J., Peeters, M., Perez, D., Robinson, B., Strickland, A., Ferguson, T., Rodrigez, J., Kroening, H., Wolf, I., Ganju, V., Walpole, E., Boucher, E., Tichler, T., Gebski, V., Van Buskirk, M., Gibbs, P.

المصدر: Annals of Oncology ; volume 26, page iv115 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1093/annonc/mdv235.18
https://api.elsevier.com/content/article/PII:S0923753419509103?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753419509103?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/26/suppl_4/iv115/333005/mdv235.18.pdf

المؤلفون: Price, T.J., Zannino, D., Wilson, K., Simes, R.J., Cassidy, J., Van Hazel, G.A., Robinson, B.A., Broad, A., Ganju, V., Ackland, S.P., Tebbutt, N.C.

المساهمون: unconditional grant from Roche

المصدر: Annals of Oncology ; volume 23, issue 6, page 1531-1536 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1093/annonc/mdr488
https://api.elsevier.com/content/article/PII:S0923753419387186?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753419387186?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/23/6/1531/402751/mdr488.pdf

المؤلفون: Segelov E., Waring P.M., Tejpar S., Khasraw M., Van Hazel G.A., Simes J., Gebski V.J., Desai J., Shapiro J.D., Thavaneswaran S., Underhill C.R., Robledo K.P., Karapetis C.S., Day F.L., Nott L.M., Jefford M., Chantrill L.A., Pavlakis N., Tebbutt N.C., Price T.J.

مصطلحات الفهرس: multicenter study, overall survival, phase 2 clinical trial, progression free survival, quality of life, randomized controlled trial, rectum, sigmoid, skin disease/si [Side Effect], transverse colon, article, treatment duration, unspecified side effect/si [Side Effect], B Raf kinase/ec [Endogenous Compound], adult, metastatic colorectal cancer/dt [Drug Therapy], monotherapy, disease exacerbation, drug efficacy, drug safety, drug tolerability, female, human, loading drug dose, male, metastatic colorectal cancer/dm [Disease Management], molecularly targeted therapy, aged, cetuximab/ae [Adverse Drug Reaction], cetuximab/cb [Drug Combination], cetuximab/cm [Drug Comparison], cetuximab/dt [Drug Therapy], cetuximab/to [Drug Toxicity], cetuximab/iv [Intravenous Drug Administration], epidermal growth factor receptor/ec [Endogenous Compound], irinotecan/ae [Adverse Drug Reaction], irinotecan/cb [Drug Combination], irinotecan/cm [Drug Comparison], irinotecan/dt [Drug Therapy], K ras protein/ec [Endogenous Compound], phosphatidylinositol 3 kinase/ec [Endogenous Compound], Ras protein/ec [Endogenous Compound], unclassified drug, n ras protein/ec [Endogenous Compound], cancer combination chemotherapy, cancer resistance, clinical article, controlled study, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/37234
Clinical Colorectal Cancer
Click here for full text options
LibKey Link

المؤلفون: Ganju V., Gibbs P., Heinemann V., Sharma N.K., Findlay M.P.N., Ricke J., Peeters M., Perez D., Robinson B.A., Ferguson T., Rodriguez J., Kroening H., Wolf I., Walpole E.T., Strickland A., Van Hazel G.A., Van Buskirk M., Gebski V., Tichler T.E., Boucher E.

مصطلحات الفهرس: resin, radiotherapy, patient, human, metastatic colorectal cancer, digestive system cancer, arm, liver, disease course, lung, chemotherapy, liver injury, liver metastasis, risk assessment, reading, imaging, bevacizumab, yttrium 90, microsphere, Conference Abstract

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/40405
Click here for full text options
LibKey Link

المؤلفون: Eliadis P., Rodriguez J., Kroning H., Wolf I., Ganju V., Walpole E., Boucher E., Tichler T., Shacham-Shmueli E., Powell A., Ferguson T., Isaacs R., Price D., Moeslein F., Taieb J., Bower G., Gebski V., Van Buskirk M., Cade D.N., Thurston K., Gibbs P., Van Hazel G.A., Heinemann V., Sharma N.K., Findlay M.P.N., Ricke J., Peeters M., Perez D., Robinson B.A., Strickland A.H.

مصطلحات الفهرس: risk assessment, splenomegaly, stomach ulcer/co [Complication], thrombocytopenia/si [Side Effect], vomiting/si [Side Effect], bevacizumab/ae [Adverse Drug Reaction], bevacizumab/ct [Clinical Trial], bevacizumab/cb [Drug Combination], bevacizumab/dt [Drug Therapy], corticosteroid/dt [Drug Therapy], diuretic agent/dt [Drug Therapy], fluorouracil/ae [Adverse Drug Reaction], fluorouracil/ct [Clinical Trial], fluorouracil/cb [Drug Combination], fluorouracil/dt [Drug Therapy], folinic acid/ae [Adverse Drug Reaction], folinic acid/ct [Clinical Trial], folinic acid/cb [Drug Combination], folinic acid/dt [Drug Therapy], low molecular weight heparin/dt [Drug Therapy], microsphere, oxaliplatin/ae [Adverse Drug Reaction], oxaliplatin/ct [Clinical Trial], oxaliplatin/dt [Drug Therapy], resin, yttrium 90, radiation hepatitis/co [Complication], radiation hepatitis/dt [Drug Therapy], selective internal radiation therapy, oxaliplatin/cb [Drug Combination], article, ascites/co [Complication], cancer combination chemotherapy, cancer radiotherapy, cancer survival, controlled study, diarrhea/si [Side Effect], drug efficacy, drug safety, duodenum ulcer/co [Complication], fatigue/si [Side Effect], febrile neutropenia/co [Complication], febrile neutropenia/si [Side Effect], hepatitis/co [Complication], hepatitis/dt [Drug Therapy], human, abdominal pain/si [Side Effect], adult, aged, female, intermethod comparison, liver, liver failure/co [Complication], liver failure/dt [Drug Therapy], liver resection, lung embolism/si [Side Effect], major clinical study, male, metastatic colorectal cancer/dt [Drug Therapy], metastatic colorectal cancer/rt [Radiotherapy], multicenter study, multimodality cancer therapy, nausea/si [Side Effect], neutropenia/si [Side Effect], peripheral neuropathy/si [Side Effect], phase 3 clinical trial, priority journal, progression free survival, radiation injury/co [Complication], radiation injury/dt [Drug Therapy], randomized controlled trial, respiratory failure/co [Complication], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39664
Journal of Clinical Oncology
Click here for full text options
LibKey Link

المؤلفون: Gibbs P., Strickland A., Ganju V., Walpole E., Boucher E., Tichler T., Gebski V., Van Buskirk M., Van Hazel G.A., Heinemann V., Sharma N.K., Findlay M.P.N., Ricke J., Peeters M., Perez D., Robinson B., Ferguson T., Rodrigez J., Kroening H., Wolf I.

مصطلحات الفهرس: neutropenia, epidemiology, safety, Kaplan Meier method, risk assessment, cause of death, hazard ratio, follow up, metastasis, stratification, bevacizumab, yttrium 90, microsphere, digestive system cancer, patient, metastatic colorectal cancer, duodenum ulcer, chemotherapy, toxicity, intention to treat analysis, imaging, progression free survival, disease course, lymph node metastasis, lung, liver metastasis, resin, human, radiotherapy, liver, arm, Conference Abstract

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41219
Click here for full text options
LibKey Link

المؤلفون: Sharma, Ricky A., Van Hazel, G.A., Morgan, B., Berry, David P., Blanshard, K., Price, D., Bower, G., Shannon, J.A., Gibbs, P., Steward, William P.

وصف الملف: Metadata

Relation: RAE 2007; Journal of Clinical Oncology, 2007, 25 (9), pp.1099-1106; http://hdl.handle.net/2381/1215

الاتاحة: http://hdl.handle.net/2381/1215
https://doi.org/10.1200/JCO.2006.08.7916

المؤلفون: Tichler T., Strickland A., Walpole E., Boucher E., Gebski V., Van Buskirk M., Gibbs P., Van Hazel G.A., Heinemann V., Sharma N.K., Findlay M.P.N., Ricke J., Peeters M., Perez D., Robinson B., Ferguson T., Rodrigez J., Kroening H., Wolf I., Ganju V.

مصطلحات الفهرس: metastatic colorectal cancer, Australia, neoplasm, liver, arm, chemotherapy, stratification, reading, follow up, epidemiology, risk assessment, safety, metastasis, disease course, bevacizumab, yttrium 90, resin, microsphere, patient, liver metastasis, human, society, radiotherapy, Conference Abstract

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41286
Click here for full text options
LibKey Link

المؤلفون: Ganju V., Dobrovic A., Tebbutt N.C., Parry M.M., Zannino D., Strickland A.H., Van Hazel G.A., Pavlakis N., Mellor D., Gebski V.J.

مصطلحات الفهرس: febrile neutropenia/si [Side Effect], acne/si [Side Effect], anorexia/si [Side Effect], article, cancer survival, clinical article, controlled study, diarrhea/si [Side Effect], drug efficacy, drug safety, esophagogastric cancer/dt [Drug Therapy], esophagus cancer/dt [Drug Therapy], gene mutation, human, multicenter study, multiple cycle treatment, nausea/si [Side Effect], overall survival, phase 2 clinical trial, priority journal, progression free survival, quality of life, randomized controlled trial, stomach cancer/dt [Drug Therapy], stomatitis/si [Side Effect], survival time, treatment response, B Raf kinase/ec [Endogenous Compound], cetuximab/ae [Adverse Drug Reaction], cetuximab/ct [Clinical Trial], docetaxel/dt [Drug Therapy], K ras protein/ec [Endogenous Compound], docetaxel/cb [Drug Combination], docetaxel/ct [Clinical Trial], docetaxel/ae [Adverse Drug Reaction], cetuximab/dt [Drug Therapy], cetuximab/cb [Drug Combination], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27666
Click here for full text options
LibKey Link

المؤلفون: Yadav S.K., Zalcberg J.R., Taylor M., Strickland A.H., Tomiak A.T., Yip D., Simes J., Links M., Karapetis C.S., Van Hazel G.A., Tu D., Tebbutt N.C., Jonker D.J., Jefford M., Burnell M.J., Price T.J., O'Callaghan C.

مصطلحات الفهرس: progression free survival, tumor volume, colorectal cancer, chemotherapy, overall survival, tumor, multivariate analysis, therapy, monotherapy, patient, human, wild type, mutant, molecularly targeted therapy, cetuximab, Conference Abstract

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29929
Click here for full text options
LibKey Link

المؤلفون: Howard J., Parker S., Welby S., Page F., Corker M., Wykes R., Goss C., Whitney S., Oates J., Soulis E., Hoque M., Gebbie C., Tebbutt N.C., Wilson K., Gebski V.J., Cummins M.M., Zannino D., Van Hazel G.A., Robinson B., Broad A., Ganju V., Ackland S.P., Forgeson G., Cunningham D., Saunders M.P., Stockler M.R., Chua Y., Zalcberg J.R., Simes R.J., Price T.J., Price T., Coates A., O'Connell D., Brown C., Hague W., France A., Hicks S., James R., Masson R., O'Connell R., Pike R., Shoulder J., Stevens L., Tunney V., Vachan B., Wong N., Ackland S., Moylan E., Strickland A., Abdi E., Ransom D., Lowenthal R., Marx G., Nayagam S.S., Shannon J., Goldstein D., Karapetis C., Blum R., Eek R., Ward R., Pavlakis N., Wilcken N., Burns I., Wyld D., Underhill C., Claringbold P., Liauw W., Clingan P., Jefford M., Horvath L., McKendrick J., Chong G., Boyce A., Cassidy J., Kirsten F., Clarke S., Guo Y., Innes-Rowe J., Smith A., Williams J., Tournier E., Maliepaard S., Vitullo E., Humm G., Nguyen V., Midolo P., Chorlton C., McDonald L., Oliver L., Sjursen A.-M., Inglis C., Marafioti T., McCourt J., Richards A., Provis A., Rundle A., Whatman A., Emmett L., Raymond B., Byrne S., Withers E., Campbell J., Hodgkins C., Szwajcer M.

مصطلحات الفهرس: colorectal cancer/dt [Drug Therapy], diarrhea/si [Side Effect], fatigue/si [Side Effect], febrile neutropenia/si [Side Effect], female, hand foot syndrome/si [Side Effect], hemolytic uremic syndrome/si [Side Effect], human, hypertension/si [Side Effect], infection/si [Side Effect], intestine perforation/si [Side Effect], major clinical study, male, metastasis/dt [Drug Therapy], multicenter study, nausea/si [Side Effect], neutropenia/si [Side Effect], New Zealand, overall survival, phase 3 clinical trial, priority journal, progression free survival, proteinuria/si [Side Effect], quality of life, randomized controlled trial, side effect/si [Side Effect], stomatitis/si [Side Effect], thrombocytopenia/si [Side Effect], thromboembolism/si [Side Effect], treatment response, United Kingdom, vein embolism/si [Side Effect], vein thrombosis/si [Side Effect], vomiting/si [Side Effect], bevacizumab/ae [Adverse Drug Reaction], bevacizumab/ct [Clinical Trial], bevacizumab/cb [Drug Combination], bevacizumab/cm [Drug Comparison], bevacizumab/dt [Drug Therapy], capecitabine/ae [Adverse Drug Reaction], capecitabine/ct [Clinical Trial], capecitabine/cb [Drug Combination], capecitabine/cm [Drug Comparison], capecitabine/dt [Drug Therapy], mitomycin/ae [Adverse Drug Reaction], Australia, mitomycin/cb [Drug Combination], mitomycin/cm [Drug Comparison], mitomycin/dt [Drug Therapy], bleeding/si [Side Effect], mitomycin/ct [Clinical Trial], adult, aged, article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30424
Journal of Clinical Oncology
Click here for full text options
LibKey Link